Article

Time to enhance re-treatment of LASIK overcorrections

Author(s):

David Roncone, OD,Philip C. Roholt, MD

The incidence of overcorrection after LASIK for myopia is low, but the results of re-treatment are variable. Re-treating often results in a shift back to myopia, leaving the patient unhappy. To improve the results of LASIK enhancement surgery, a new formula is warranted. In 1999, Drs. Lindstrom and co-workers noted that laser treatment achieved different effects in eyes with primary versus secondary hyperopia. They attributed this effect to dynamics of wound healing.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Related Content
(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 2nd 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 2nd 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Navigate successful cataract surgery with refractive technology
August 2nd 2025

Navigate successful cataract surgery with refractive technology

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 2nd 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
August 2nd 2025

Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

ForSight Robotics completes $125M Series B funding to address global surgeon shortage
August 2nd 2025

ForSight Robotics completes $125M Series B funding to address global surgeon shortage

© 2025 MJH Life Sciences

All rights reserved.